日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The urinary albumin-to-creatinine ratio can direct personalized prevention and treatment for cardiovascular and chronic kidney disease

尿白蛋白/肌酐比值可指导心血管疾病和慢性肾脏病的个体化预防和治疗。

期刊:Journal of Internal Medicine
影响因子:9.2
doi:10.1111/joim.70066
Kramer, Holly J; Bakris, George L
心血管疾病
心血管
发表日期：2026
文献求助 收藏

The Role of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Cardiovascular-Kidney-Metabolic Syndrome

胰高血糖素样肽-1受体激动剂在心血管-肾脏-代谢综合征治疗中的作用

期刊:JACC Advances
影响因子:
doi:10.1016/j.jacadv.2025.102465
Kumar, Sonal; Anderson, John E; Coviello, Andrea; Lopez-Jimenez, Francisco; Bakris, George L
信号转导
代谢综合征
代谢
发表日期：2026
文献求助 收藏

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial

型糖尿病患者接受索玛鲁肽治疗后，根据慢性肾脏病严重程度评估其心血管结局：FLOW 试验

期刊:European Heart Journal
影响因子:35.6
doi:10.1093/eurheartj/ehae613
Mahaffey, Kenneth W; Tuttle, Katherine R; Arici, Mustafa; Baeres, Florian M M; Bakris, George; Charytan, David M; Cherney, David Z I; Chernin, Gil; Correa-Rotter, Ricardo; Gumprecht, Janusz; Idorn, Thomas; Pugliese, Giuseppe; Rasmussen, Ida Kirstine Bull; Rasmussen, Søren; Rossing, Peter; Sokareva, Ekaterina; Mann, Johannes F E; Perkovic, Vlado; Pratley, Richard
糖尿病
代谢
发表日期：2025
文献求助 收藏

Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial

菲奈利酮联合标准治疗对非糖尿病慢性肾脏病患者肾脏疾病进展的影响（FIND-CKD）随机试验的设计和基线特征

期刊:Nephrology Dialysis Transplantation
影响因子:5.6
doi:10.1093/ndt/gfae132
Heerspink, Hiddo J L; Agarwal, Rajiv; Bakris, George L; Cherney, David Z I; Lam, Carolyn S P; Neuen, Brendon L; Sarafidis, Pantelis A; Tuttle, Katherine R; Wanner, Christoph; Brinker, Meike D; Dizayee, Sara; Kolkhof, Peter; Schloemer, Patrick; Vesterinen, Paula; Perkovic, Vlado
糖尿病
代谢
发表日期：2025
文献求助 收藏

Design and rationale of the eLym™ System for Decompensation of Excess Lymphatic Fluid via the Thoracic Duct in Acute Heart Failure (DELTA-HF)

eLym™系统通过胸导管治疗急性心力衰竭（DELTA-HF）中淋巴液过多失代偿的设计和原理

期刊:Esc Heart Failure
影响因子:3.7
doi:10.1002/ehf2.15192
Biegus, Jan; Lindenfeld, JoAnn; Felker, G Michael; Bakris, George; Jonas, Michael; Lala, Anuradha; Kereselidze, Zviad; Khabeishvili, George; Gogorishvili, Irakli; Núñez, Julio; Bayés-Genís, Antoni; Ponikowski, Piotr; Abraham, William T
心力衰竭
心血管
发表日期：2025
文献求助 收藏

Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes

非奈利酮与慢性肾脏病和2型糖尿病患者的左心室肥厚

期刊:Esc Heart Failure
影响因子:3.7
doi:10.1002/ehf2.14962
Filippatos, Gerasimos; Anker, Stefan D; Bakris, George L; Rossing, Peter; Ruilope, Luis M; Coats, Andrew J S; von Haehling, Stephan; Ponikowski, Piotr; Rosano, Giuseppe M C; Brinker, Meike; Farjat, Alfredo E; Roberts, Luke; Pitt, Bertram
糖尿病
代谢
发表日期：2025
文献求助 收藏

Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis

在患有 2 型糖尿病和慢性肾脏病的患者中，使用或不使用盐皮质激素受体拮抗剂联合使用司美格鲁肽的疗效：FLOW 试验预设的二次分析

期刊:
影响因子:
doi:10.2337/dc25-0472
Rossing, Peter; Bakris, George; Perkovic, Vlado; Pratley, Richard; Tuttle, Katherine R; Mahaffey, Kenneth W; Idorn, Thomas; Belmar, Nicolas; Bosch-Traberg, Heidrun; Rasmussen, Søren; Busch, Robert S; Schmieder, Ronald E; Gillard, Pieter; Mann, Johannes F E
代谢
糖尿病
信号转导
免疫/内分泌
发表日期：2025
文献求助 收藏

Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF

美国退伍军人中，伴有射血分数保留型心力衰竭 (HFpEF)、射血分数中间值型心力衰竭 (HFmrEF) 和射血分数降低型心力衰竭 (HFrEF) 的 KDIGO 定义的慢性肾脏病 (CKD) 的预后

期刊:Jacc-Heart Failure
影响因子:
doi:10.1016/j.jchf.2024.11.007
Patel, Samir; Raman, Venkatesh K; Faselis, Charles; Fonarow, Gregg C; Lam, Phillip H; Ahmed, Amiya A; Heidenreich, Paul A; Anker, Stefan D; Deedwania, Prakash; Morgan, Charity J; Zhang, Sijian; Moore, Hans; Rangaswami, Janani; Bakris, George; Butler, Javed; Sheriff, Helen M; Allman, Richard M; Zeng-Treitler, Qing; Wu, Wen-Chih; Ahmed, Ali
心力衰竭
心血管
发表日期：2025
文献求助 收藏

RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial

RNA干扰联合齐来贝西兰治疗轻中度高血压：KARDIA-1随机临床试验

期刊:Journal of the American Medical Association
影响因子:55
doi:10.1001/jama.2024.0728
Bakris, George L; Saxena, Manish; Gupta, Anil; Chalhoub, Fadi; Lee, Jongtae; Stiglitz, Daniel; Makarova, Nune; Goyal, Nitender; Guo, Weinong; Zappe, Dion; Desai, Akshay S
心血管
高血压
发表日期：2024
文献求助 收藏

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

FLOW试验中，司美格鲁肽联合或不联合SGLT2抑制剂治疗2型糖尿病合并慢性肾病患者的疗效

期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-024-03133-0
Mann, Johannes F E; Rossing, Peter; Bakris, George; Belmar, Nicolas; Bosch-Traberg, Heidrun; Busch, Robert; Charytan, David M; Hadjadj, Samy; Gillard, Pieter; Górriz, José Luis; Idorn, Thomas; Ji, Linong; Mahaffey, Kenneth W; Perkovic, Vlado; Rasmussen, Søren; Schmieder, Roland E; Pratley, Richard E; Tuttle, Katherine R
SGLT2
糖尿病
代谢
发表日期：2024
文献求助 收藏